Table 4 Prevalence of TEEs in ROS1-rearranged NSCLC in different studies
Study | Country | Study type | Total patients | TEEs observation period | Incidence |
|---|---|---|---|---|---|
Ng et al. [9] | USA, China | Retrospective cohort study | 95 | Within ±90 days of diagnosis | 34.7% |
Chiari et al. [10] | Italy | Randomized controlled trial | 48 | From diagnosis to last follow up or death | 41.6% |
Alexander et al. [11] | Australia | Retrospective cohort study | 42 | 1-year prior to diagnosis until the last study follow-up | 47.6% |
Muñoz-Unceta et al. [12] | Spain, Portugal | Retrospective cohort study | 58 | 6 months before diagnosis to last follow up or death | 46.6% |
Current study | China | Retrospective cohort study | 47 | 3 months before diagnosis to 6 months after diagnosis | 23.4% |